http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-10343815-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_319eed6d6813db49e8057bdaa5e60233 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-775 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-92 |
| filingDate | 2003-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91340286c8d969ab7586cff9bf0f7719 |
| publicationDate | 2005-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | DE-10343815-A1 |
| titleOfInvention | Method for the diagnosis of diseases under the determination of apolipoprotein C-I, and its use in the therapy of diseases |
| abstract | methodnfor diagnosis, early diagnosis,nrisk assessmentnas well as for the follow-up of illnesses, in which one in onenSerum or plasma sample of a human patient the content of apolipoproteinnC-I and / or its derivativesndetermined and due to a significantly determined by normal healthy personsnValue range deviating result of the determination on the existencena disease, in particular a tumor disease or anSepsis, closes,nand the use of apolipoprotein C-I for therapy and preventionnof disorders in which the amount or the binding capacitynof apolipoprotein C-I in the blood of patients to normal personsnchanged significantlynis. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008064883-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AT-502227-B1 |
| priorityDate | 2003-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 251.